Vildagliptin Recruiting Phase 3 Trials for Insulin Dependent Diabetes / Juvenile Onset Diabetes Mellitus / Type 1 Insulin-Dependent Diabetes Mellitus / Diabetes, Autoimmune Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01559025Evaluation of Vildagliptin (GalvusĀ®) as add-on to Insulin in New-onset Type 1 Diabetes Mellitus